Cabbacis Licenses Low-Nicotine Tobacco From NCSU
2024年6月24日 - 9:28PM
ビジネスワイヤ(英語)
Cabbacis (the “Company”), a U.S. federally-licensed tobacco
product manufacturer and plant biotech company focused on harm
reduction products, announced today that it has licensed a
flue-cured, low-nicotine tobacco line from North Carolina State
University (NCSU).
The novel tobacco line was produced by utilizing
naturally-occurring mutations in tobacco genes. No genetic
engineering or genetic modifications were utilized which greatly
facilitates the international planting of this low-nicotine
tobacco. Also, commercial products made from this tobacco line,
which was produced from traditional plant breeding techniques, will
have marketing and consumer acceptance advantages over
genetically-engineered, low-nicotine counterparts.
Patents have been filed on this proprietary low-nicotine tobacco
line which has been grown in field trials conducted by NCSU. On
average, it contains about ninety-five percent (95%) less nicotine
than conventional flue-cured tobacco used in commercial cigarette
brands. Cabbacis is currently growing this low-nicotine tobacco on
several acres.
Mr. Pandolfino, the Company’s CEO stated, “I am quite pleased
that Cabbacis has obtained formal rights to this novel,
low-nicotine tobacco line. I’ve had licensing relationships through
various companies with NCSU since 1998, and I look forward to
another mutually beneficial relationship with the university.”
In addition to an upfront license fee, Cabbacis will also pay
NCSU annual license fees, running royalties on sales and milestone
payments. The Company will also cover patent expenses and any
expenses related to filing plant variety right (PVR)
applications.
About Cabbacis
Cabbacis is committed to developing and commercializing
reduced-nicotine cigarettes and vaporizer pods. Both types of
products in development are comprised predominately of tobacco and
include hemp. The Company stands ready to also move forward with
reduced-nicotine tobacco cigarettes without hemp.
Reduced-nicotine cigarettes without hemp that contain about 95
percent less nicotine than conventional cigarettes have been
evaluated in dozens of independent studies. Results demonstrate
that subjects smoked fewer cigarettes per day, reduced their
nicotine dependence and exposure, doubled their quit attempts,
and/or increased their number of smoke-free days. The Company
believes including hemp flower in reduced-nicotine cigarettes
improves taste and sensory characteristics and will improve
effectiveness.
The Company’s worldwide patent portfolio includes 32 issued
patents and various pending patent applications across the United
States, Europe, China, India, Japan, Indonesia, Russia, South
Korea, Canada, Australia, New Zealand, Mexico, Brazil and other
countries — where approximately two-thirds of the world’s smokers
reside. The Company holds 6 U.S. patents. Cabbacis Inc wholly owns
Cabbacis LLC.
To learn more about Cabbacis, please visit
www.cabbacis.com.
Cautionary Note Regarding Forward-Looking Statements
This press release includes forward-looking statements within
the meaning of the federal securities law. All statements other
than statements of historical or current facts made in this
document are forward-looking. We identify forward-looking
statements in this document by using words or phrases such as
"anticipate," "believe," “consider,” "continue," "could,"
"estimate," "expect," “foresee,” "intend," “likely,” "may,"
"objective," "potential," "plan," "predict," "project," "seek,"
“should,” "will" and similar words or phrases and their negatives.
Forward-looking statements reflect our current expectations and are
inherently uncertain. Actual outcomes or results could differ
materially for a variety of reasons. Factors that could cause
actual results to differ materially are described in “Risk Factors”
in our Regulation A Offering Circular filed with the SEC and in our
Annual Report on Form 1-K for the period ended December 31, 2023
filed with the SEC. We undertake no responsibility to publicly
update or revise any forward-looking statement except as required
by applicable law.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy the Company’s securities, nor shall
there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of that
state or jurisdiction.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240624607350/en/
Media Tracy Witman support@cabbacis.com